Abstract

Bone marrow transplantation (BMT) has revolutionized the treatment landscape for various hematologic malignancies and non-malignant disorders, offering a potential cure or long-term disease control. Historically, BMT was predominantly considered a treatment option for younger patients due to concerns about treatment-related toxicity and transplant-related mortality in older adults. However, recent advancements in transplantation techniques, supportive care measures, and patient selection criteria have expanded the feasibility and efficacy of BMT in older adult populations. This article explores the latest reports and advancements in BMT specifically tailored to older adults, highlighting the outcomes, challenges, and opportunities in this evolving field.